While the study suggests that APP could be undergoing somatic retro-insertion (which can be mediated by retrotransposons such as L1), it remains unclear if these novel APP variants have a pathogenic role in Alzheimer’s disease, or if they are a by-product of other underlying pathogenic mechanisms. This evidence concerns the gene APP and Alzheimer disease.